Thanks for the post! Really well reasoned on the broad impact of malovelence.
1. It seems that any research on manipulation proof measures for detection for malevolence, would help the development of tools that would be useful for a totalitarian state.
2. I’m sceptical of further research on malevolence being helpful in stopping these people being in positions of power. At first glance I don’t think a really well developed literature on malevolence, would of changed leaders coming to power in 20th century.
3. In terms of Public engagement, I am also sceptical (eg. jon ronson the psychopath test) as I suspect that making people want more altruistic people in charge, is hard to move needle on. (Interesting piece on malevelonce in leaders https://theconversation.com/narcissists-and-psychopaths-how-some-societies-ensure-these-dangerous-people-never-wield-power-118854)
4. In terms of development of genetically engineered individuals, I think it really matters more who is in charge. I doubt bio-ethicists saying dark triad traits are bad will have much of an effect. In terms of further GWAS studies, I suspect by the time this becomes feasible more GWAS on desirable personality traits will have been undertaken. And it seems that work done ahead of time will be less useful, due to earlier studies being superseded by studies with more advanced technology .
Some Psychiatric medication that has shown widespread use in Russia is unlicensed in Western countries. Some of these medications have RCTs showing benefit, eg. Afobazole showed increased anxiolytic properties when compared to diazepam and no withdrawal. Does this suggest that already existing compounds that patents aren’t owned by drug company will not achieve widespread use, how will physcedelics differ? How will physcedelics have RCTs (randomised controlled trials) conducted that compared to pre-existing treatments, look at long term efficacy and safety, and appropriate dose be funded that will help with approval by bodies such as NICE/FDA? The route of esketamine, (a form of Ketamine administered as a nasal spray patented by J&J for treatment resistant depression) seems to have significant drawbacks: high cost, no RCT compared to pre-existing treatments, how is this improved upon for physcedelics.